Argos Therapeutics (ARGS) Tops Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. DOX
4. AMGN
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Argos Therapeutics (ARGS) Tops Q4 EPS by 4c

Argos Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results and Operational Highlights

March 29, 2016 4:30 PM EDT

- Completed Patient Enrollment in Pivotal Phase 3 ADAPT Clinical Trial of AGS-003 in July 2015  

- Independent Data Monitoring Committee (IDMC) Recommended Continuation of Pivotal Phase 3 ADAPT Clinical Trial of AGS-003 Following Data Reviews in June and December 2015 - 

- Established Scientific Advisory Board in July 2015  

- Early stage RCC trial of AGS-003 Commenced at Roswell Park Cancer Institute in July 2015 - 

- Conference Call and Webcast Today, March 29th, at 4:30 p.m. ET -

DURHAM, N.C., March 29, 2016 (GLOBE NEWSWIRE) --... More